IndraLab

Statements


PARP1 inhibits USP3. 1 / 1
| 1

reach
"Importantly, inhibition and/or deletion of PARP1 or USP3 restores transcriptional recovery in XRCC1 -/- cells, highlighting PARP1 and USP3 as possible therapeutic targets in neurological disease."